Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Frequently asked questions What is the triple agonists (GLP-1/GIP/glucagon) drug class
Orthopaedic Sports Medicine Systematic Review (PMC, 2024) A systematic review of BPC-157 in orthopaedic sports medicine conducted via searches of PubMed, Cochrane, and Embase from inception to June 2024 confirmed pre-clinical evidence across fractures, tendon ruptures, ligament tears, and muscle injuries, documenting BPC-157s ability to modulate growth factor expression and enhance fibroblast migration to injury sites across all studied tissue types
This page does not provide dosing, administration, reconstitution, treatment, or human-use guidance
Studies have demonstrated that GLS2 is the essential subtype for mitochondrial regulation of ferroptosis (GAO et al., 2015
Secondary endpoints included the change from baseline of Foot and Ankle Outcome Score (FAOS)/ Cumberland Ankle Instability Tool (CAIT)/ FAAM activities of daily living (ADL) subscale, number of ankle sprains during study period, incident ankle surgery in treatment of CAI
Retatrutide does not yet have a confirmed recommended dose, as it is still in clinical trials
US$ 23.07
US$ 25.56
US$ 23.52
